Epithalon

Epithalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide developed at the St. Petersburg Institute of Bioregulation and Gerontology, studied for its capacity to activate telomerase, regulate pineal gland function, and extend cellular lifespan markers in both animal and human research. Cellular aging has a measurement. It is the length of your telomeres, the protective caps on every strand of DNA in every cell you have. They shorten with each division, and shorter telomeres correlate with accelerated biological aging across virtually every marker researchers have examined. Epithalon is the synthetic form of Epithalamin, a natural polypeptide your pineal gland produces. A gland that begins declining in output in your 20s and approaches near-total suppression by your 60s. Professor Vladimir Khavinson and his team at the St. Petersburg Institute spent 35 years producing more longevity-focused clinical data on this compound than almost any peptide in the field. Research has shown Epithalon to activate telomerase in somatic cells, the enzyme that rebuilds telomere length. Investigators have also examined its role in restoring melatonin secretion, normalizing circadian rhythms that drift with age, and recalibrating the hypothalamic-pituitary-adrenal axis. Animal studies observed meaningful lifespan extension. Human studies recorded telomere elongation in peripheral blood cells. What the research describes, in aggregate, is a compound that interacts with the core machinery of biological aging at multiple levels simultaneously. For researchers studying longevity mechanisms, that is a rare profile.